chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client complained of numbness and tingling in Right arm 15 minutes following vaccine administration. Denied any other symptoms such as SOB, HA, CP or numbness and tingling of mouth, face or lips. Client denied any pertinent medical history, medication use, or allergies to any medications/foods/environment. At 1138 a first set of vitals taken: BP 150/98, HR: 64, RR: 16, A&Ox4, bilateral grip was equal and strong and bilateral capillary refill was >2 seconds. Client stated the numbness was rated an 8/10 in discomfort. Skins were warm, dry and normal for ethnicity. Client stated she had a history of high blood pressures that were untreated. Bilateral hands were cool to touch and client complained of feeling cold. Client stated last oral intake was at dinner the evening before. Client ambulated to zero gravity chair without incidence and was given a foil blanket, juice and granola bar. At 1147 a second set of vitals taken: BP 132/92, RR: 16, HR: 80, A&Ox4. Client stated the numbness and tingling had migrated to left arm as well as right arm, and stated, "it feels like when your arm falls asleep", continued to deny SOB, CP, HA, and tingling of mouth and face. At 1205 a third set of vitals taken: BP 142/84, RR 16, HR: 64. Client continued complaint of numbness and tingling of bilateral hands and arms. Denied SOB, HA, CP or any other symptoms. At 1210 vitals taken BP 138/90, HR 70, RR 14. Client stated otherwise feels fine, but continued complaint of light headed, feeling cold and numbness and tingling in bilateral arms and hands. Client's skin was warm, dry and normal color for ethnicity. At 1215 vitals taken: BP 136/86, RR 16, HR 72, A&Ox4, bilateral grip: equal and strong, bilateral capillary refill >2 seconds. Client continued to complain of feeling numbness in arms and hands. At 1220 client asked to use the restroom, stated she was feeling "woozy" upon sitting up from zero gravity reclined position. Client stated she would like to be assessed by EMS as she was not improving. At 1225 EMS called at client's request. At 1232 client care transferred to EMS. Client continued to have stable vital signs and no other distress or symptoms. Client signed AMA from EMS care at 1237. At 1240 client educated on ER precautions and advised to follow up with PCP if numbness and tingling persist or worsened. Client verbalized understanding and left the observation site on her own accord with a steady gait.
Information has been received from a pharmacist referring to a 66 year old female patient. The patient's pertinent medical history included hypertension, rheumatoid arthritis and gastrooesophageal reflux disease (GERD). The patient was allergic to erythromycin. In June 2012, the patient was vaccinated with ZOSTAVAX, 0.65 ml, subcutaneously (lot # 1716AA, expiration date 02-FEB-2013, strength unknown). The patient took unspecified medications as concomitant Medication. On 12-NOV-2015 (reported as three weeks ago), the patient experienced unspecified blisters on the left side of her stomach and she was seen in the office by the physician on 03-DEC-2015. The patient was diagnosed with shingles by the physician and was prescribed acyclovir on the same day. No lab test was performed. The outcome of the event was reported as not recovered. Causality between event and ZOSTAVA was not reported. Additional information has been requested.
7/12/21: headache, tiredness 7/13/21: sore throat, headache, fever 100.6, neck/shoulder pain 7/14/21: fever 100, back/ kidneys in pain, no appetite 7/15/21: headache, tiredness, back ache, lost 4 lbs 7/16/21: upper back pain 7/17/21: tested positive for COVID-19 7/18/21: upper back pain when breathing, go to ER: pleurisy, other tests negative  7/19/21: lost sense of smell, congestion 7/20/21: congestion w/ mucus 7/21/21: tiredness, congestion with mucus
After the vaccine, I was a little tired and the injection site hurt. I did not get a fever, but I was a bit worn out. The shoulder pain ended up getting worse as time went on. I went to my primary care who did X-rays but saw no damage. I started physical therapy in July. The therapy has helped but there is still some discomfort when I raise my arms.
pt recv vax 21OCT97 & pt exp large knot @ the inj site & was treated w/cold compresses;
Very sore arm, swollen and red with what looked like bruising extending from the should to under my arm and armpit.  Lasted 3 or 4 days as best I remember.  The "bruising" lasted at least a week or so before it was noticeably fading.
pt recvd 3 doses of Hep B vax in FEB91, MAR91, & 20SEP91 & 28SEP91 devel numbness of 4th & 5th fingers; heaviness of the entire arm; pain in the cervical area of the neck that radiated down the lt shoulder to lt arm;
About 24 hours after flu vaccine, developed tingling/pain on left side of face that radiated to back of head. Pain similar to a trigeminal neuralgia. 48 hours later, the tingling/numbness was in both side of face with dull headache. About 5 days later, the tingling/numbness subsided but there was a pain in lower jaw, pain with chewing
Large area of erythema on Rt. deltoid approximately 5 inches long by 4 inches wide. Treatment with Benadryl and cool compresses.
Patient received wrong formulation for age.  He received the pediatric dose 0.2 ml for 5-11 y.o. instead of 0.3 ml for 12 and older Pfizer.
This spontaneous report was received from a social media user, as part of a marketing research program and refers to an unspecified number of female patients of unknown age. There was no information about the patients concurrent conditions, concomitant therapies or medial histories provided. On unknown dates, the patients were vaccinated with GARDASIL injection (exact dose, dose number, route of administration, anatomical location, lot # and expiration date were not reported. It was reported that, the patients (reported as "girls") had suffered adverse effects from GARDASIL for years (onset dates and details were unspecified). The outcome of adverse effects was unknown. The reporter considered adverse event to be related to GARDASIL. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored RECOMBIVAX HB lot # M032649 with expiration date of 11-NOV-2018, lot # M044031 with expiration date of 21-FEB-2019 and lot # M039642 with expiration date of 03-JUL-2019 (doses, route of administration, anatomical location and thimerosal status were not provided). No adverse effects were reported. Administered doses of vaccine underwent a temperature excursion of 48.7 degrees Fahrenheit (F) for 13 hours which was detected by a data logger. There were no previous excursions reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA009409: US-009507513-1704USA002131: US-009507513-1704USA009408.
reporter state pt t101.8,BP 130/94 c/o weak-dizzy;pt carried to ER;c/o figity feeling trembling,don't remember everything that happened;mom says pt seen by ER MD;t102;lab studies all neg;no treatment given;
Large red circular local reaction at injection site. Started day after IM injection. No pain, no fevers.  Of note, pediatrician (for unknown reason) administered TWO flu vaccines this season. Last one was 9/2020.
Nausea, fatigue, headache; arm swelled, hot, red, painful. Couldn't straighten out arm for days.
The patient developed fever and confusion with thrombocytopenia.  She was admitted to ICU with hypotension on non-invasive ventilatory support.  Work up in progress.   Husband reported similar reaction with prior COVID shots and was worried about getting this one.  This reaction has been the worst.
fatigue; headache; chills; joint pain; swelling lymph node; injection site pain; This spontaneous case was reported by an other health care professional and describes the occurrence of CHILLS (chills), ARTHRALGIA (joint pain), LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (chills), ARTHRALGIA (joint pain), LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain). On 26-Feb-2021, CHILLS (chills) outcome was unknown. At the time of the report, ARTHRALGIA (joint pain) outcome was unknown and LYMPHADENOPATHY (swelling lymph node) and VACCINATION SITE PAIN (injection site pain) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-027396.
This spontaneous report as received from a pharmacy technician refers to a 4 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 12-MAR-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
Several hours after patient received her 1st Prevnar vaccine in her right lateral thigh, her parents described her thigh as "swelling to twice its normal size" and noted fussiness and swelling around her eyelids. They took her to a nearby ER, where swelling and induration of the right lateral injection site was noted. There was no wheezing or drooling, and no swelling noted around the eyes. Her vital signs were all normal. She was given Tylenol and sent home.
COVID19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID19) (seriousness criterion hospitalization). At the time of the report, COVID-19 (COVID19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided. Treatment medication information was not provided.  Company comment: Based on the mechanism of action of mRNA1273, it does not cause Covid 19, therefore the event is unlikely related to the vaccine.; Sender's Comments: Based on the mechanism of action of mRNA1273, it does not cause Covid 19, therefore the event is unlikely related to the vaccine.
Irritated one side of the face; Swelling of the eyes; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL NEURALGIA (Irritated one side of the face) and EYE SWELLING (Swelling of the eyes) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), Eve primrose and CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) for an unknown indication.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced FACIAL NEURALGIA (Irritated one side of the face) and EYE SWELLING (Swelling of the eyes). At the time of the report, FACIAL NEURALGIA (Irritated one side of the face) and EYE SWELLING (Swelling of the eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
On 10/1/13, she received a flu shot in the Wellness Center at work at 9:45 AM and went back to work. She did not feel well but didn't return to the Wellness Center because she had a subsequent doctor's appointment at 1:30 PM. When she got to the doctor's office she had chills, shivering, body aches, fever 104 F. Her doctor gave her epinephrine and benedryl and sent her home, telling her if she felt worse, go to the hospital.  At home she felt worse and was admitted to the hospital. She called me at the Wellness Center at 9 AM this morning, 10/2/13, to tell me all the above.
syncope --- patient walked to her chair for 15 minute observation period after vaccine and sat down.  after approximately 1 minute, she slumped over, fell out of her chair and hit her head on the floor.  she was conscious, but not able to move or keep her eyes open.  we had her transported to hospital via ambulance due to her head injury.  she was released to home same day after concussion evaluation.
Developed rash around belly button and on thighs- chicken pox looking rash with temp received varicella 2/26/09.
- Chest & throat tightened making it difficult to breathe* - Swollen itchy eyes - Dizzy - Blurred, hazy vision - Confusion - Hoarse voice - Weakness  *Used my Ventolin inhaler to help breathe
Initial unsolicited report received from a pharmacist on 21-Jul-2017. This case involves a 64-year-old male patient, who was vaccinated with second dose of ADACEL (batch number: U5702AA, expiry date: 20-Jun-2019; dose, route not reported) in right deltoid on 12-Jul-2017. Patient's illness at time of vaccination was none and pre-existing physician diagnosed allergies birth defects, medical conditions were reported as hypothyroidism. Concomitant medications were not reported. No other vaccinations within 4 weeks of vaccinations was given. On an unknown date, following the vaccination, the patient's arm still hurts. Patient required ER/doctor visit. No lab test was performed. As part of corrective treatment patient took NAPROXEN (ALLEVE) but did not helped. Patient did not recovered form the event. Documents held by sender: none.
2/9/12-1st lightheaded, metallic taste in mouth, dizzyness, high systolic BP x3, q5 min: 186/80, 180/80, 153/83, normal systolic 120, HR WNL. Ct feels reaction r/t anxiousness prior to vaccination, 'I don't like shots' , Ref to PCP, appt w/ ENT on 03/02/21.
Returned call to mother. Mom stated that child had Dtap earlier in the day at health department and was suffering from a "reaction". Mom reports child vomited x 1 in car after leaving Health Department, felt hot to touch, and cried for 20 minutes. Mother denies any seizures, pain, shortness of breath, additional vomiting, or swelling at site. Mother could not take temperature due to not having a thermometer. She states that child has stopped crying, and not vomited since. Instructed mom to take child to ER or call 911 if any seizure like activity, swelling of face or trouble breathing occurs. Mom agreed in instruction. Educated on mild to moderate reactions to INFANRIX Vaccine. Also educated to take child to primary care doctor for additional vaccines for further monitoring of reactions. Mom stated that she was making child an appointment with doctor's office. This was the first vaccine child has ever received.
The week following my booster I experienced a TIA in my left frontal lobe secondary to a DVT in my left femoral vein. This event put me in the hospital for 3 days. I had blood tests performed for clotting abnormalities which were negative, a heart monitor to  rule out arrhythmias, and a full body CT to rule out cancers.
pt presented with leg swelling and shortness of breath and decreased kidney funtion followed by cardio and nephrology. pt asymptomatic for covid was test at d/c for snf placement.
Patient presented with symptoms of DVT on 05/15 at Urgent Care. Was admitted to ER on 05/17 to treat DVT
On 1/3/2023 pt. came in to continue her Hepatitis B Vaccine (Engerix) series. She had received her 1st dose on 11/1/2022, her 2nd dose on 12/5/2022 and was due to receive her 3rd dose on 5/1/2023. Her early vaccination was not noted during verification or prior to administration.
Doses three months apart; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Doses three months apart) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Doses three months apart). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Doses three months apart) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Patient traveled out of the country and missed 2nd dose, almost 3 months apart. Treatment information was not provided.
My daugther got a rash all over her body, fever, red/bloody looking diarrhea, and vomiting. Vomiting was only one or twice. I think that she is also experiencing arm pain because something she walks around holding her arm.
I had slight spasms and pulsating immediately  at the site of the shot. About an hour or two later I had a slight burning up my arm from where the injection was. I developed a severe headache on the right side of my head the next day and it has continued on the second day.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: Unknown. The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1), for COVID-19 immunization. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "moderate AFib". Clinical information: I received the 2nd Pfizer Covid Vaccine and am now diagnosed with moderate AFib. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Swollen, hot, red, itchy rash at injection site that is still getting larger after 48 hours of vaccine.
This spontaneous report was received from a nurse refers to a patient of an unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date in May 2011, the patient received 2 doses of CERVARIX. On an unknown date in December 2012, the patient was vaccinated with first dose of GARDASIL (lot#, dose and route of administration were not reported). On an unknown date in June 2013, the patient was vaccinated with second dose of GARDASIL (lot#, dose and route of administration were not reported). No adverse effects were reported. Additional information has been requested.
On 03/14/2002 left arm swollen and red since 03/13/2002. Received shots on 03/12/2002, hurts to touch. Left arm 3" x 5" red mild induration, reaction to DTaP. Was given Benadryl at night.
Increased pain in arm after vaccine that progressed over the course of 3 weeks and now starting to improve.
This case was reported by a pharmacist via call center representative and described the occurrence of eyelid disorder in a 72-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020). On 30th March 2018, the patient received SHINGRIX (intramuscular). On 31st March 2018, 1 days after receiving SHINGRIX, the patient experienced eyelid disorder. The patient was treated with Eye Drop Medication and antihistamine, antihistamine, antihistamine, Antihistamine. On an unknown date, the outcome of the eyelid disorder was recovering/resolving. The reporter considered the eyelid disorder to be possibly related to SHINGRIX. Additional details were provided as follows: This case was not previously reported to anyone. The patient received SHINGRIX vaccine on the left arm. The next day after SHINGRIX vaccination, the patient noted a bump on her eyelid. The pharmacist described it as stye-like. The patient used an unspecified over the counter eye drop with an antihistamine and there was slight improvement.
About 2 days after my injection, the pain at the injection site has subsided, but my entire left shoulder became stiff and sore. My range of motion has been affected, and simple tasks like putting on a jacket have become painful. Prior to my vaccine, I did not have this issue.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Jan2021 as dose 1, single (Lot number: EK9231), in right arm, on 30Jan2021 as dose 2, single (Lot number: EL9262), in right arm, on 20Dec2021 as dose 3 (booster), single (Lot number: FE3590), in right arm and on 22Jul2022 at 13:15 as dose 4 (booster), single (Lot number: FM9992) at the age of 63 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: NORTRIPTYLINE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient received Valicyclovir medication in 2 weeks from 17Aug2022 to 19Aug2022. The patient had no known allergies.
The patient states she's had constant pain over her entire left arm with radiation to the upper left torso and a left sided headache since approximately 6 hours after receiving her third Japanese Encephalitis vaccine in her left arm in my office 4 days ago. She describes the pain as a constant burning sensation that seems to have worsened with time. She denies hives, rashes, erythemia, edema, sore throat or shortness of breath. She has an appointment scheduled with her family physician in a few hours and states she will get back to me after the appointment.
Fever 103, exhaustion, aches, respiratory symptoms, increased shortness of breath, nausea, lightheaded like going to pass out
Information has been received from a registered nurse concerning a 6-year-old female child who on 19-MAY-2000 and 19-APR-2001 was vaccinated with a first (administered SC) and second doses of Varivax. On 07-JUL-2005, the patient developed Varivax. The outcome was reported as recovered. Additional information has been requested.
Patient came to office to receive 2nd hepatitis B vaccine and influenza vaccine was administered instead. CDC contacted. Mom states no adverse reactions.
Headache, Myalgia, Fever & NauseaVomiting Narrative: Missed work due to the above symptoms following second dose
SIRVA left shoulder beginning 1 day s/p vaccine administration. Left shoulder pain, numbness, limited range of motion.